---
title: "Reanalysis of isotope-resolved metabolomics in patient-derived lung cancer tissue: treatment- and"
id: "medrxiv-1-treatment-and-tissue-context-specific-isotope-labeling-patterns-in-patient"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-1-treatment-and-tissue-context-specific-isotope-labeling-patterns-in-patient"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.15.26368161v1?rss=1"
published_at: "2026-11-19T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Reanalysis of isotope-resolved metabolomics in patient-derived lung cancer tissue: treatment- and
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-1-treatment-and-tissue-context-specific-isotope-labeling-patterns-in-patient
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.15.26368161v1?rss=1)
- **Published At:** 2026-11-19T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Investigators reanalyzed a publicly deposited **stable-isotope-resolved metabolomics** dataset derived from patient lung cancer tissue cultures, focusing on treatment and tissue context. - The source dataset included 38 tissue samples from two patients (matched tumor and non-tumor slices from one patient and a factorial treatment experiment in tumor tissue from a second patient); the exact per-group counts were reported in the source. - Tracers used in the original experiment were U-13C6-glucose and U-13C5,15N2-glutamine; treatments included vehicle, **pembrolizumab**, and a WGP β-glucan combination in one tumor experiment. - The reanalysis recomputed protein-normalized pools, isotopologue distributions, atom-percent excess, and pathway summaries from the deposited data and code. - Effects were quantified using log2-scale linear models, Hedges' g for effect size, and exact randomization tests that enumerated all compatible assignments for each experimental design. - The study team observed several directionally consistent labeling changes: increases in labeled non-oxidative pentose phosphate intermediates, weighted isotopic scrambling, and glutamine-derived glutathione diversion in one patient; an increased labeled IMP/(ATP+GTP+UTP) ratio in the other. - Statistical support varied: some model P values were small, but exact permutation tests produced larger P values and no endpoint survived Benjamini–Hochberg correction at q < 0.05 in the exact analyses. - Authors noted the reanalysis reproduced the original study's principal labeling directions but emphasized the limited statistical resolution of small patient-derived experiments and framed results as hypothesis-generating. - Data and analysis code are available from Dryad and as Supporting Information per the source report.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=JuJ38aSd96pSdeBAuG10EGfhmZTv7295AkQtOmGhJcE-1795173935.1211112-1.2.1.1-SxfXkCrnPVCRkap8UskKyoqjT0ZPVhaUU.wsPTGhasO0FTzh8MIjC_390FpTsoDT) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.15.26368161v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # # Treatment- and tissue-context-specific isotope labeling patterns in patient-derived lung cancer tissues: an independent reanalysis of public metabolomics data [ View ORCID Profile](http://orcid.org/0009-0002-4400-433X)Zhijie Shang, Hong Geng doi: https://doi.org/10.64898/2026.11.15.26368161 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Zhijie Shang 1 Shanxi Bethune Hospital; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Zhijie%2BShang%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Shang%20Z&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AZhijie%2BShang%2B) * [ORCID record for Zhijie Shang](http://orcid.org/0009-0002-4400-433X "Open in new tab") * For correspondence: shangzhijie@sxbqeh.com.cn Hong Geng 2 Yuci District People's Hospital * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Hong%2BGeng%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Geng%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHong%2BGeng%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.15.26368161v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1349316/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.15.26368161v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1349316/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.15.26368161v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1349316/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.15.26368161v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1349316/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.15.26368161v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1349316/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Publicly deposited stable-isotope-resolved metabolomics data can be reanalyzed independently, but small patient-derived experiments may produce treatment effects with limited statistical resolution. We reanalyzed a public isotope-resolved metabolomics dataset from patient-derived lung cancer tissue cultures to quantify treatment- and tissue-specific labeling patterns and their uncertainty. We used 38 tissue samples from two patients: matched tumor and non-tumor slices from UK131 treated with vehicle or pembrolizumab and traced with U-13C6-glucose or U-13C5,15N2-glutamine (n = 3 per cell), and a pembrolizumab × WGP β-glucan factorial experiment in UK2035 tumor tissue (n = 3/3/3/2). We recomputed protein-normalized pools, isotopologue distributions, atom-percent excess and pathway summaries. Effects were estimated with log2-scale linear models, Hedges' g, and exact randomization tests that enumerated all assignments compatible with each design; Benjamini–Hochberg q values were calculated within endpoint families. Sixteen macrophage samples were examined only descriptively. In UK131 tumor tissue, labeled non-oxidative pentose phosphate pathway intermediates increased 1.84-fold (model P = 0.036; exact tumor P = 0.10; exact interaction P = 0.16; q = 0.32). Weighted isotopic scrambling increased 1.31-fold (exact interaction P = 0.04; q = 0.20), and glutamine-derived glutathione diversion increased 1.66-fold (exact interaction P = 0.09; q = 0.22). In UK2035, the combination increased the labeled IMP/(ATP+GTP+UTP) ratio 3.64-fold (model interaction P = 3.2 × 10-4; exact P = 0.016; q = 0.097). No endpoint survived Benjamini–Hochberg correction at q Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.15.26368161v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.11.16.26368244v1 "Promoter methylation of LDLR is not a common cause of familial hypercholesterolemia")[Next ](https://www.medrxiv.org/content/10.64898/2026.11.18.26368387v1 "Perinatal suicide risk factors: A network analysis") Posted November 19, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.15.26368161v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/19/2026.11.15.26368161.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.15.26368161v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/19/2026.11.15.26368161.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) # Treatment- and tissue-context-specific isotope labeling patterns in patient-derived lung cancer tissues: an independent reanalysis of public metabolomics data Zhijie Shang, Hong Geng medRxiv 2026.11.15.26368161; doi: https://doi.org/10.64898/2026.11.15.26368161 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.15.26368161v1%26text%3D%2523%2520Treatment-%2520and%2520tissue-context-specific%2520isotope%2520labeling%2520patterns%2520in%2520patient-derived%2520lung%2520cancer%2520tissues%253A%2520an%2520independent%2520reanalysis%2520of%2520public%2520metabolomics%2520data "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.15.26368161v1%26t%3D%2523%2520Treatment-%2520and%2520tissue-context-specific%2520isotope%2520labeling%2520patterns%2520in%2520patient-derived%2520lung%2520cancer%2520tissues%253A%2520an%2520independent%2520reanalysis%2520of%2520public%2520metabolomics%2520data "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.15.26368161v1%26title%3D%2523%2520Treatment-%2520and%2520tissue-context-specific%2520isotope%2520labeling%2520patterns%2520in%2520patient-derived%2520lung%2520cancer%2520tissues%253A%2520an%2520independent%2520reanalysis%2520of%2520public%2520metabolomics%2520data%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.15.26368161v1%26title%3D%2523%2520Treatment-%2520and%2520tissue-context-specific%2520isotope%2520labeling%2520patterns%2520in%2520patient-derived%2520lung%2520cancer%2520tissues%253A%2520an%2520independent%2520reanalysis%2520of%2520public%2520metabolomics%2520data "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.11.15.26368161) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.11.15.26368161v1&count=horizontal&via=&text=%23%20Treatment-%20and%20tissue-context-specific%20isotope%20labeling%20patterns%20in%20patient-derived%20lung%20cancer%20tissues%3A%20an%20independent%20reanalysis%20of%20public%20metabolomics%20data&counturl=www.medrxiv.org/content/10.64898/2026.11.15.26368161v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (642) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (927) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (355) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (5055) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (496) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (432) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (681) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1703) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16341) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (37) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1248) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7329) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (760) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1101) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5348) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1480) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1847) * [Hematology](https://www.medrxiv.org/collection/hematology) (604) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1389) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16535) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1209) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (702) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (157) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (757) * [Neurology](https://www.medrxiv.org/collection/neurology) (7659) * [Nursing](https://www.medrxiv.org/collection/nursing) (380) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1142) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1306) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1045) * [Oncology](https://www.medrxiv.org/collection/oncology) (3766) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1105) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (413) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (473) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (506) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (144) * [Pathology](https://www.medrxiv.org/collection/pathology) (726) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1877) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (758) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (791) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (6184) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (10048) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2560) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1538) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1280) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (666) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (814) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (601) * [Surgery](https://www.medrxiv.org/collection/surgery) (809) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (109) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (321) * [Urology](https://www.medrxiv.org/collection/urology) (309) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this article: _There are no community reviews for this paper._ Automated Evaluations Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv. Automated Evaluations: _There are no automated evaluations for this paper._ Blog/Media Links medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Video medRxiv partners with conferences and institutions to display recordings of talks and seminars related to preprints. These are posted with the consent of the authors. Video: _There are no videos for this paper._ Powered by [![Hypothes.is logo](https://connect.biorxiv.org/eval/hypothesis.png)](https://web.hypothes.is/) Powered by [![Altmetric logo](https://connect.biorxiv.org/eval/altmetric.png)](https://www.altmetric.com/) ## Follow this preprint X You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the [medRxiv Alerts Page](ht
## Related Clinical Research

- [Immune checkpoint inhibitor–induced diabetes in metastatic NSCLC: case report, management, and fol](https://medichelpline.com/clinical-feed/frontiers-in-immunology-16-immune-checkpoint-inhibitor-induced-diabetes-mellitus-in-metastatic-nsclc-a.md)
- [Beyond conventional biomarkers: editorial on novel biomarkers and combinatorial approaches for imm](https://medichelpline.com/clinical-feed/frontiers-in-immunology-16-editorial-beyond-conventional-biomarkers-unlocking-immunotherapy-response.md)
- [Sacituzumab tirumotecan plus pembrolizumab shows activity in PD-L1–negative NSCLC](https://medichelpline.com/clinical-feed/nature-reviews-clinical-oncology-1-sacituzumab-tirumotecan-pembrolizumab-has-efficacy-in-pd-l1-negative-nsclc.md)
- [Perioperative ivonescimab ± chemotherapy Yields High MPR in Resectable NSCLC (Phase 2)](https://medichelpline.com/clinical-feed/nature-1-perioperative-ivonescimab-with-or-without-chemotherapy-in-resectable-non-small.md)
- [Phase III data: First-line regimens for advanced NSCLC with EGFR exon 20 insertions and PD-L1+ dis](https://medichelpline.com/clinical-feed/pubmed-42755291.md) (DOI: 10.1158/2159-8290.CD-NW2026-0090)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.